Literature DB >> 22004793

Nasal route: an alternative approach for antiemetic drug delivery.

Yildiz Ozsoy1, Sevgi Güngör.   

Abstract

INTRODUCTION: Antiemetic drugs are used in the treatment of nausea and emesis. Development of novel delivery systems for antiemetic drugs, as an alternative to conventional preparations, is important in terms of good patient compliance and improving bioavailability. The nasal route offers unique superiorities, such as fast and high drug absorption, and high patient compliance. Therefore, a considerable amount of research has been carried out on the development of nasal delivery systems for antiemetic drugs. AREAS COVERED: This review deals with the importance of nasal delivery of antiemetic drugs and the studies performed on this subject. The first part of this review summarizes the properties of the nasal route, its advantages and limitations, parameters affecting drug absorption through nasal mucosa, nasal passage pathways and general approaches to improve nasal transport. The second part reviews the studies conducted on the development of nasal delivery systems. EXPERT OPINION: Due to its superiorities, the nasal route could be considered as an attractive alternative to oral and parenteral routes. To overcome the barrier properties of the nasal epithelium and to enhance transport of antiemetic drugs, several approaches, including permeation enhancers, in situ gel formulations and micro- and nanoparticulate systems, have been evaluated. The results obtained are promising and indicate that nasal formulations of some antiemetic drugs may enter the market in the near future.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22004793     DOI: 10.1517/17425247.2011.607437

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  5 in total

Review 1.  Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview.

Authors:  Elena Giuliano; Donatella Paolino; Massimo Fresta; Donato Cosco
Journal:  Pharmaceutics       Date:  2018-09-12       Impact factor: 6.321

Review 2.  Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs.

Authors:  Andrew Lofts; Fahed Abu-Hijleh; Nicolette Rigg; Ram K Mishra; Todd Hoare
Journal:  CNS Drugs       Date:  2022-06-27       Impact factor: 6.497

Review 3.  The Mucoadhesive Nanoparticle-Based Delivery System in the Development of Mucosal Vaccines.

Authors:  Kai Zhao; Yinzhuo Xie; Xuezheng Lin; Wei Xu
Journal:  Int J Nanomedicine       Date:  2022-09-28

4.  Intranasally administered in situ gelling nanocomposite system of dimenhydrinate: preparation, characterization and pharmacodynamic applicability in chemotherapy induced emesis model.

Authors:  Sara S Barakat; Maha Nasr; Rania F Ahmed; Sabry S Badawy; Samar Mansour
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

5.  Human Lactobacillus Biosurfactants as Natural Excipients for Nasal Drug Delivery of Hydrocortisone.

Authors:  Elisa Corazza; Angela Abruzzo; Barbara Giordani; Teresa Cerchiara; Federica Bigucci; Beatrice Vitali; Massimiliano Pio di Cagno; Barbara Luppi
Journal:  Pharmaceutics       Date:  2022-02-26       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.